Terpyridine-Zn(II) based water-soluble fluorescent probes for selective detection of pyrophosphate ions in aqueous medium and its bioimaging application in living cells

Abstract

Pyrophosphate (PPi) is a key biomarker for various cellular processes and human diseases and thus the development of receptors to bind selectively with PPi ions and facilitate the monitoring of intracellular PPi concentration in living cells is highly imperative. In the present study, novel water-soluble terpyridine-Zn(II) complexes-based fluorescent probes [TPD-Zn2]Cl4 and [TPTBr-Zn2]Cl4 have been designed and synthesized for the selective and sensitive detection of pyrophosphate (PPi) ions in aqueous environment as well as in living cells. The selectivity investigations of both the fluorescent probes towards different anions in HEPES buffer (pH = 7.4) showed highly selective binding towards PPi ions even in the presence of other concomitant nucleotides. Both the probes [TPD-Zn2]Cl4 and [TPTBr-Zn2]Cl4 have exhibited linear fluorescence enhancement upon the addition of different concentrations of PPi and this enhancement in the intensity could be attributed to the photoinduced electron transfer (PET) inhibition process. This proposed binding mechanism was demonstrated using fluorescence and NMR spectroscopic titrations and also the interaction of [TPD-Zn2]Cl4 and [TPTBr-Zn2]Cl4 probes with PPi ions was examined in detail using density functional theory (DFT) analysis. The Job’s plot has shown the binding of complexes between [TPD-Zn2]Cl4 and [TPTBr-Zn2]Cl4 and PPi in 1:2 stoichiometry and the probes have shown excellent binding affinity towards PPi ions with binding constants of 7.72 × 105 M−2 and 6.74 × 104 M−2, respectively. Noticeably, both the probes exhibited promising sensitivity towards PPi with detection limits as low as 0.47 nM and 0.17 nM, respectively. Cytotoxicity studies of [TPD-Zn2]Cl4 and [TPTBr-Zn2]Cl4 revealed that both the probes are biocompatible and subsequently their diagnostic efficacy as bioimaging probes was demonstrated through monitoring the intracellular PPi concentrations in breast cancer cells (MCF-7).